HANSOH PHARMAC. HD-00001 (3KY) — Cash Flow-to-Debt Ratio
HANSOH PHARMAC. HD-00001 (3KY) has a Cash Flow-to-Debt Ratio of 1.49x as of December 2025, meaning its operating cash flow of €6.74 Billion could theoretically repay 1% of its total liabilities (€4.54 Billion) in one year. Check cash flow reinvestment rate of HANSOH PHARMAC. HD-00001 to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
HANSOH PHARMAC. HD-00001 Cash Flow-to-Debt Ratio (2021–2025)
Historical debt coverage capacity for HANSOH PHARMAC. HD-00001 across 5 annual periods. Check HANSOH PHARMAC. HD-00001 cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Annual Cash Flow-to-Debt Ratio for HANSOH PHARMAC. HD-00001 (2021–2025)
Year-by-year debt coverage analysis for HANSOH PHARMAC. HD-00001. For the full cash flow conversion analysis, see HANSOH PHARMAC. HD-00001 (3KY) cash conversion ratio.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 1.49x | €6.74 Billion | €4.54 Billion | ▲ +14.5% |
| 2024 | 1.30x | €3.86 Billion | €2.98 Billion | ▲ +201.5% |
| 2023 | 0.43x | €3.12 Billion | €7.24 Billion | ▲ +15.4% |
| 2022 | 0.37x | €2.74 Billion | €7.35 Billion | ▲ +3.1% |
| 2021 | 0.36x | €2.58 Billion | €7.13 Billion | — |